6533b824fe1ef96bd1281635
RESEARCH PRODUCT
Transanal total mesorectal excision for restorative coloproctectomy in an obese high-risk patient with colitis-associated carcinoma
Hauke LangWerner KneistFlorian HeidSebastian FörschFabian BartschLaura Isabel Hankesubject
Riskmedicine.medical_specialtyPancolitisAnal CanalRectumAnastomosisInflammatory bowel disease03 medical and health sciences0302 clinical medicineCarcinomaHumansAscending colonMedicineObesitybusiness.industryAnastomosis SurgicalProctocolectomy RestorativeRectumMiddle Agedmedicine.diseaseTotal mesorectal excisionUlcerative colitisSurgerymedicine.anatomical_structure030220 oncology & carcinogenesisColonic NeoplasmsColitis UlcerativeFemaleLaparoscopy030211 gastroenterology & hepatologySurgerymedicine.symptombusinessdescription
Transanal total mesorectal excision (TaTME) offers great potential for the treatment of malign and benign diseases. However, laparoscopic-assisted TaTME in ulcerative colitis has not been described in more than a handful of patients. We present a 47-year-old highly comorbid female patient with an ulcerative colitis-associated carcinoma of the ascending colon and steroid- refractory pancolitis. A two-stage restorative coloproctectomy including right-sided complete mesocolic excision was conducted. The second step consisted of a successful nerve-sparing TaTME and a handsewn ileal pouch-anal anastomosis. TaTME may extend the possible treatment options in inflammatory bowel disease, especially for high-risk patients.
| year | journal | country | edition | language |
|---|---|---|---|---|
| 2016-11-26 | Minimally Invasive Therapy & Allied Technologies |